Mechanisms of long COVID: An updated review

Yan Liu1,2, Xiaoying Gu3, Haibo Li1

  • 1National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.

Insights

Long COVID, persistent symptoms after SARS-CoV-2 infection, affects many patients regardless of initial disease severity. Vaccination can reduce long COVID rates, but its mechanisms remain unclear.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • The COVID-19 pandemic has caused significant global health and economic disruption.
  • Long COVID, characterized by persistent symptoms post-SARS-CoV-2 infection, affects individuals irrespective of initial illness severity.
  • Common symptoms include fatigue, dyspnea, and multi-organ involvement.

Purpose of the Study:

  • To review the clinical presentations of long COVID.
  • To summarize current evidence on the pathogenesis of long COVID.
  • To provide an overview of long COVID prevalence across different SARS-CoV-2 variants.

Main Methods:

  • This study is a narrative review.
  • It synthesizes existing literature on long COVID.
  • It examines clinical data and research on disease mechanisms.

Main Results:

  • Long COVID is prevalent across various SARS-CoV-2 variants and disease severities.
  • Vaccination is associated with reduced incidence of long COVID.
  • The underlying mechanisms driving long COVID are not yet fully understood.

Conclusions:

  • Long COVID presents a complex clinical challenge with multi-systemic implications.
  • Further research into the pathogenesis is crucial for developing effective treatments.
  • Understanding long COVID is essential for managing the long-term health consequences of the pandemic.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...